Critical Survey: Marblegate Acquisition (NASDAQ:GATE) and OSR (NASDAQ:OSRH)

OSR (NASDAQ:OSRH) and Marblegate Acquisition (NASDAQ:GATE) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Profitability

This table compares OSR and Marblegate Acquisition’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Marblegate Acquisition	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent ratings for OSR and Marblegate Acquisition, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1	0	0	0	1.00
Marblegate Acquisition	0	0	0	0	0.00

Volatility & Risk

OSR has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, Marblegate Acquisition has a beta of -0.5, indicating that its share price is 150% less volatile than the S&P 500.

Valuation & Earnings

This table compares OSR and Marblegate Acquisition”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.91 million	4.03	-$27.06 million	($0.33)	-1.01
Marblegate Acquisition	N/A	N/A	-$2.39 million	N/A	N/A

Marblegate Acquisition has lower revenue, but higher earnings than OSR.

Institutional & Insider Ownership

55.3% of OSR shares are owned by institutional investors. Comparatively, 9.4% of Marblegate Acquisition shares are owned by institutional investors. 36.8% of OSR shares are owned by insiders. Comparatively, 71.2% of Marblegate Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Marblegate Acquisition beats OSR on 5 of the 9 factors compared between the two stocks.

About OSR

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

About Marblegate Acquisition

Marblegate Acquisition Corp. does not have significant operations. The company focuses on effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies primarily in the education, business services, consumer products, and healthcare sectors. The company was incorporated in 2020 and is based in Rye, New York.